ATE437941T1 - Verfahren zur erzeugung von beta-inselzellen aus exokrinen pankreaszellen - Google Patents

Verfahren zur erzeugung von beta-inselzellen aus exokrinen pankreaszellen

Info

Publication number
ATE437941T1
ATE437941T1 AT04737673T AT04737673T ATE437941T1 AT E437941 T1 ATE437941 T1 AT E437941T1 AT 04737673 T AT04737673 T AT 04737673T AT 04737673 T AT04737673 T AT 04737673T AT E437941 T1 ATE437941 T1 AT E437941T1
Authority
AT
Austria
Prior art keywords
cells
island
exocrine pancreas
generating beta
beta
Prior art date
Application number
AT04737673T
Other languages
English (en)
Inventor
Luc Bouwens
Luc Baeyens
Original Assignee
Vrije Universiteit Brussel Vub
Opus Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vrije Universiteit Brussel Vub, Opus Nv filed Critical Vrije Universiteit Brussel Vub
Application granted granted Critical
Publication of ATE437941T1 publication Critical patent/ATE437941T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/22—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from pancreatic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04737673T 2003-06-20 2004-06-21 Verfahren zur erzeugung von beta-inselzellen aus exokrinen pankreaszellen ATE437941T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03447164 2003-06-20
PCT/BE2004/000089 WO2004113512A2 (en) 2003-06-20 2004-06-21 Method of generating islet beta-cells from exocrine pancreatic cells

Publications (1)

Publication Number Publication Date
ATE437941T1 true ATE437941T1 (de) 2009-08-15

Family

ID=33522524

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04737673T ATE437941T1 (de) 2003-06-20 2004-06-21 Verfahren zur erzeugung von beta-inselzellen aus exokrinen pankreaszellen

Country Status (13)

Country Link
US (1) US7604991B2 (de)
EP (1) EP1636348B1 (de)
JP (1) JP2007520194A (de)
AT (1) ATE437941T1 (de)
CA (1) CA2527626A1 (de)
CY (1) CY1109474T1 (de)
DE (1) DE602004022292D1 (de)
DK (1) DK1636348T3 (de)
ES (1) ES2330438T3 (de)
PL (1) PL1636348T3 (de)
PT (1) PT1636348E (de)
SI (1) SI1636348T1 (de)
WO (1) WO2004113512A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009103637A1 (en) * 2008-02-22 2009-08-27 Vrije Universiteit Brussel Method for generating islet beta cells from dedifferentiated exocrine pancreatic cells
WO2014004341A1 (en) 2012-06-26 2014-01-03 Seraxis, Inc. Stem cells and pancreatic cells useful for the treatment of insulin-dependent diabetes mellitus
WO2015088072A1 (ko) * 2013-12-11 2015-06-18 한국과학기술원 인간 다능성 줄기세포로부터 인슐린 생산 배타세포의 내분비 응집체의 제조방법
WO2016179106A1 (en) * 2015-05-01 2016-11-10 University Of Miami Methods and compositions for converting non-endocrine pancreatic tissue into insulin-producing cells
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU739771B2 (en) * 1995-10-25 2001-10-18 University Of Florida Research Foundation, Inc. In vitro growth of functional islets of langerhans and in vivo uses thereof
US7056734B1 (en) * 1998-08-10 2006-06-06 The United States Of America As Represented By The Department Of Health And Human Services, Nih Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof
KR19990014353A (ko) * 1998-10-17 1999-02-25 윤태욱 췌도의 대량 배양증식방법
US6815203B1 (en) * 1999-06-23 2004-11-09 Joslin Diabetes Center, Inc. Methods of making pancreatic islet cells
CA2388208A1 (en) * 1999-10-29 2001-05-10 Mcgill University Medium for preparing dedifferentiated cells
US6610535B1 (en) * 2000-02-10 2003-08-26 Es Cell International Pte Ltd. Progenitor cells and methods and uses related thereto
ES2299417T3 (es) 2000-04-12 2008-06-01 Beta-Cell N.V. Metodo para producir preparaciones de celulas endocrinas pancreaticas madura e inmaduras, preparacion de las celulas y su utilizacion para el tratamiento de la diabetes mellitus.
FR2814752A1 (fr) * 2000-10-02 2002-04-05 Chru Lille Procede d'obtention in vitro de cellules insulino- secretrices de mammifere et leurs utilisations
WO2003102171A1 (en) * 2002-05-28 2003-12-11 Becton, Dickinson And Company Expansion and transdifferentiation of human acinar cells

Also Published As

Publication number Publication date
EP1636348A2 (de) 2006-03-22
DE602004022292D1 (de) 2009-09-10
DK1636348T3 (da) 2009-11-23
JP2007520194A (ja) 2007-07-26
WO2004113512A2 (en) 2004-12-29
SI1636348T1 (sl) 2010-01-29
US20070292388A1 (en) 2007-12-20
PT1636348E (pt) 2009-10-21
CY1109474T1 (el) 2014-08-13
US7604991B2 (en) 2009-10-20
ES2330438T3 (es) 2009-12-10
CA2527626A1 (en) 2004-12-29
EP1636348B1 (de) 2009-07-29
WO2004113512A3 (en) 2005-03-31
PL1636348T3 (pl) 2010-01-29

Similar Documents

Publication Publication Date Title
Bourgeois et al. Towards a functional cure for diabetes using stem cell-derived beta cells: are we there yet?
JP6954877B2 (ja) 小分子を用いた多能性幹細胞からの膵臓内胚葉の作製
Thatava et al. Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny
Pettinato et al. Scalable differentiation of human iPSCs in a multicellular spheroid-based 3D culture into hepatocyte-like cells through direct Wnt/β-catenin pathway inhibition
Abdelalim et al. Advances and challenges in the differentiation of pluripotent stem cells into pancreatic β cells
Saito et al. Adoptive transfer of CD8+ T cells generated from induced pluripotent stem cells triggers regressions of large tumors along with immunological memory
Kang et al. Insulin-secreting cells from human eyelid-derived stem cells alleviate type I diabetes in immunocompetent mice
BRPI0819609A2 (pt) Diferenciação de células-tronco embrionárias de ser humano
SE0003508D0 (sv) Behandling av diabetes
PE20090731A1 (es) Metodos de produccion de proteinas basados en medios de cultivos celulares que comprenden compuestos anti-senescencia
RU2016100433A (ru) КЛЕТКИ SC-β И КОМПОЗИЦИИ И СПОСОБЫ ДЛЯ ИХ СОЗДАНИЯ
IN2014DN10053A (de)
KR20200015855A (ko) 만능 줄기 세포의 췌장 내배엽 세포 (pec) 및 내분비 세포로의 시험관내 분화
SA522432641B1 (ar) T تركيبة لزراعة الخلية التنظيمية واستخدامها
CY1109474T1 (el) Μεθοδος δημιουργιας β-κυτταρων νησιδιων απο ενδοκρινη παγκρεατικα κυτταρα
Wang et al. The progress of pluripotent stem cell-derived pancreatic β-cells regeneration for diabetic therapy
Lu et al. Hemangioblasts from human embryonic stem cells generate multilayered blood vessels with functional smooth muscle cells
Mittal et al. Substrate stiffness modulates the maturation of human pluripotent stem-cell-derived hepatocytes
Pan et al. Synergistic modulation of signaling pathways to expand and maintain the bipotency of human hepatoblasts
Memon et al. Toward precision medicine with human pluripotent stem cells for diabetes
Reebye et al. A short-activating RNA oligonucleotide targeting the islet β-cell transcriptional factor MafA in CD34+ cells
WO2014179198A8 (en) Methods for producing insulin-secreting beta cells from human pluripotent stem cells
Upadhye et al. Advances in stem cell–derived beta-cell therapy: A new frontier in type 1 diabetes treatment
ATE452967T1 (de) Verfahren zur herstellung menschlicher beta- zelllinien
DE60039160D1 (de) Verwendung von erbb-rezeptorliganden zur behandlung von diabetes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1636348

Country of ref document: EP

REN Ceased due to non-payment of the annual fee